279 related articles for article (PubMed ID: 33686448)
1. Pyoderma Gangrenosum: A Retrospective Study of Clinical Charac-teristics, Comorbidities, Response to Treatment and Mortality Related to Prednisone Dose.
Schøsler L; Fogh K; Bech R
Acta Derm Venereol; 2021 Apr; 101(4):adv00431. PubMed ID: 33686448
[TBL] [Abstract][Full Text] [Related]
2. [Pyoderma gangrenosum: a report of 15 cases and review of the literature].
Suárez-Pérez JA; Herrera-Acosta E; López-Navarro N; Vilchez-Márquez F; Prieto JD; Bosch RJ; Herrera E
Actas Dermosifiliogr; 2012 Mar; 103(2):120-6. PubMed ID: 21782147
[TBL] [Abstract][Full Text] [Related]
3. The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.
Ashchyan HJ; Butler DC; Nelson CA; Noe MH; Tsiaras WG; Lockwood SJ; James WD; Micheletti RG; Rosenbach M; Mostaghimi A
JAMA Dermatol; 2018 Apr; 154(4):409-413. PubMed ID: 29450453
[TBL] [Abstract][Full Text] [Related]
4. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
6. Pyoderma gangrenosum in a patient with essential thrombocythemia.
King KW; Murray A
J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
[TBL] [Abstract][Full Text] [Related]
7. [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases].
Duarte AF; Nogueira A; Lisboa C; Azevedo F
Dermatol Online J; 2009 Jul; 15(7):3. PubMed ID: 19903431
[TBL] [Abstract][Full Text] [Related]
8. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma gangrenosum: a review with special emphasis on Latin America literature.
Rodríguez-Zúñiga MJM; Heath MS; Gontijo JRV; Ortega-Loayza AG
An Bras Dermatol; 2019; 94(6):729-743. PubMed ID: 31789268
[TBL] [Abstract][Full Text] [Related]
10. [Pyoderma gangrenosum--an interdisciplinary diagnostic problem].
Torzecka JD; Kondras K; Dziankowska-Bartkowiak B; Waszczykowska E; Modzelewski B; Jurałowicz P; Kondras M
Pol Merkur Lekarski; 2008 Jan; 24(139):34-7. PubMed ID: 18634250
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features and prognosis of pyoderma gangrenosum in Korea: A single centre, retrospective, observational study over 20 years.
Kim YJ; Lee KH; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2023; 89(1):25-34. PubMed ID: 35389018
[TBL] [Abstract][Full Text] [Related]
13. Pyoderma gangrenosum: A clinico-epidemiological study.
Riyaz N; Mary V; Sasidharanpillai S; Roshin RA; Snigdha O; Latheef EN; Rahima S; Bindu V; Anupama RN; Sureshan DN; Sherjeena PV
Indian J Dermatol Venereol Leprol; 2017; 83(1):33-39. PubMed ID: 27549869
[TBL] [Abstract][Full Text] [Related]
14. Mucocutaneous pyoderma gangrenosum: a case report and literature review.
Đorđević Betetto L; Točkova O; Bergant Suhodolčan A
Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(Suppl):S10-S13. PubMed ID: 35339135
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
Argüelles-Arias F; Castro-Laria L; Lobatón T; Aguas-Peris M; Rojas-Feria M; Barreiro-de Acosta M; Soto-Escribano P; Calvo-Moya M; Ginard-Vicens D; Chaparro-Sánchez M; Hernández-Durán M; Castro-Senosiain B; Fernández-Villaverde A; García-Sánchez V; Domínguez-Muñoz E; Caunedo-Álvarez A; Herrerías-Gutiérrez JM
Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140
[TBL] [Abstract][Full Text] [Related]
16. Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid.
Nahm WJ; Mota JA; Rojas S; Hizon BJ; Gordon C
Am J Case Rep; 2018 Jul; 19():844-848. PubMed ID: 30022021
[TBL] [Abstract][Full Text] [Related]
17. [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].
Trémezaygues L; Schmaltz R; Vogt T; Reichrath J
Hautarzt; 2010 Apr; 61(4):345-53; quiz 354-5. PubMed ID: 20361320
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary pyoderma gangrenosum without cutaneous manifestations.
Sakata KK; Penupolu S; Colby TV; Gotway MB; Wesselius LJ
Clin Respir J; 2016 Jul; 10(4):508-11. PubMed ID: 25354722
[TBL] [Abstract][Full Text] [Related]
19. [Pyoderma gangrenosum: 6 cases].
El Fékih N; Kerkeni N; Kharfi M; Baccouche D; Zéglaoui F; Fazaa B; Kamoun Mohamed R
Rev Med Liege; 2010 Sep; 65(9):506-9. PubMed ID: 21086582
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum in an infant.
Torrelo A; Colmenero I; Serrano C; Vilanova A; Naranjo R; Zambrano A
Pediatr Dermatol; 2006; 23(4):338-41. PubMed ID: 16918628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
